Our primary research with Chinese physicians for each disease is informed by secondary sources that detail the Chinese healthcare system, pharmaceutical markets and disease-specific treatment guidelines. Sources are accurately translated from Chinese.
For each indication, we conduct in-depth qualitative interviews with 25-30 Chinese physicians of the appropriate specialties in the key urban areas of Shanghai, Beijing, Guangzhou and Shenzhen. Interviews are conducted in person in Chinese to provide the truest understanding of the physicians’ perspective.
Topics include:
- Key unmet needs in diagnosis and treatment
- Current treatment practices
- Attitudes towards changing treatment practices
- Drivers of treatment choice and regional variation of treatment
- Patient attitudes and willingness to pay for branded medicines
The qualitative interviews inform our survey of 90 additional Chinese physicians in Shanghai, Beijing and Guangzhou.
Topics include:
- Patient access to Western medicine
- Patient access and willingness to buy Western branded pharmaceuticals
- Patient presentation behavior and attitudes
- Screening practices
- Treatment choice and drivers
- Role of traditional Chinese medicine
- Unmet needs in diagnosis and treatment
Additional Expert Sources
The research supporting our Emerging Markets—China report series also includes insight from contacts within a number of organizations and agencies, including:
- Contacts in leading Chinese hospitals, through Millennium Research Group, a Decision Resources, Inc. company
- Chinese Center for Disease Control and Prevention (CDC)
- Ministry of Health, People’s Republic of China
- Harvard School of Public Health
- Canadian Program on Genomics and Global Health and other commercial organizations based in China, including CROs, financial firms and biopharma companies